Should You Buy, Sell or Hold J&J Stock Ahead of Q4 Results? [Yahoo! Finance]
Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Yahoo! Finance
The Zacks Consensus Estimate for fourth-quarter sales and earnings is pegged at $24.14 billion and $2.50 per share, respectively. The Zacks Consensus Estimate for 2025 earnings has declined from $10.87 per share to $10.83 per share, while that for 2026 has declined from $11.48 per share to $11.46 per share over the past 60 days. Image Source: Zacks Investment Research The healthcare bellwether's performance has been pretty impressive, with the company exceeding earnings expectations in each of the trailing four quarters. It delivered a four-quarter earnings surprise of 3.75%, on average. In the last reported quarter, the company delivered an earnings surprise of 1.08%. Image Source: Zacks Investment Research J&J has an Earnings ESP of -1.36% and a Zacks Rank #3 (Hold). You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter. Per our proven model, companies with the combination of a positive Earnings ESP and a Zacks Rank #1 (Stron
Show less
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- Is Evotec SE (EVO) One of the Best Debt-Free Penny Stocks to Buy Right Now? [Yahoo! Finance]Yahoo! Finance
- Amgen Inc. (NASDAQ:AMGN) is largely controlled by institutional shareholders who own 80% of the company [Yahoo! Finance]Yahoo! Finance
- Erythropoietin Stimulating Agents Market Size to Reach USD 16.81 Billion by 2033, Driven by Rising chronic kidney disease and Chemotherapy-Induced Anemia Cases – SNS Insider [Yahoo! Finance]Yahoo! Finance
- Amgen Inc. (AMGN): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $330.00 to $335.00. They now have an "outperform" rating on the stock.MarketBeat
AMGN
Earnings
- 11/4/25 - Beat
AMGN
Sec Filings
- 11/21/25 - Form 4
- 11/20/25 - Form 144
- 11/13/25 - Form 4
- AMGN's page on the SEC website